---
schema_version: "secwatch.filing_event.v1"
accession: "0000072331-24-000169"
form_type: "8-K"
ticker: "NDSN"
cik: "0000072331"
company_name: "NORDSON CORP"
filed_at: "2024-12-11T23:59:59+00:00"
generated_at: "2026-05-29T04:54:56.547283+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Nordson reports Q4 sales up 4% to $744M; FY2024 record sales $2.7B; guides FY2025 adjusted EPS $9.70-$10.50

## Summary
- Q4 GAAP EPS $2.12 (down from $2.22 YoY); adjusted EPS $2.78 (up from $2.71 YoY).
- Full-year adjusted EPS $9.73 (down from $9.85); EBITDA record $849M (32% of sales).
- Organic sales fell 3% in Q4; Industrial Precision Solutions segment down 3% YoY.
- Atrion Medical acquisition contributed to Medical & Fluid Solutions segment sales +19%.
- Fiscal 2025 guidance: sales $2.75-$2.87B; Q1 adjusted EPS $1.95-$2.15 on seasonally weak quarter.

## SEC filing metadata
- accession: 0000072331-24-000169
- form_type: 8-K
- ticker: NDSN
- cik: 0000072331
- company_name: NORDSON CORP
- filed_at: 2024-12-11T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/72331/000007233124000169/0000072331-24-000169-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/72331/000007233124000169/ndsn-20241211.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000072331-24-000169
- JSON: https://secwatch.observer/filing/0000072331-24-000169.json
- Plain text: https://secwatch.observer/filing/0000072331-24-000169.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.